Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis

GLIA

Volumn 57, Issue 2, 2009, Pages 119-135

  Zagami, Chrissandra J ^a,b   Beart, Philip M ^a,b   Wallis, Nicole ^a,b   Nagley, Phillip ^c   O'Shea, Ross D ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

AMPA; Astrocyte; Excitatory amino acid transporters; Excitotoxicity; Oxidative stress

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE TRANSPORTER; LINSIDOMINE; 3 MORPHOLINO SYDNONIMINE; 3-MORPHOLINO-SYDNONIMINE; AMINO ACID RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; GLUTAMIC ACID; MOLSIDOMINE; NEUROTOXIN; NITRIC OXIDE DONOR; SLC1A2 PROTEIN, MOUSE; SLC1A3 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; EXCITOTOXICITY; GLIA CELL; HOMEOSTASIS; IN VITRO STUDY; MOUSE; NERVE CELL CULTURE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINAL CORD MOTONEURON; ANIMAL; ANTERIOR HORN CELL; C57BL MOUSE; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; COCULTURE; DRUG EFFECT; GLIOSIS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTERIOR HORN CELLS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOPROTECTION; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GLUTAMIC ACID; HOMEOSTASIS; MICE; MICE, INBRED C57BL; MOLSIDOMINE; NEUROTOXINS; NITRIC OXIDE DONORS; OXIDATIVE STRESS; TIME FACTORS;

EID: 60549101137     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20739     Document Type: Article

References (63)

1. 3H](2S,4R)-4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes. J Neurosci Res 75:751-759.
2. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, Estevez AG, Beckman JS. 2004. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 47:263-274.
3. Beart PM, O'Shea RD. 2007. Transporters for L-glutamate: An update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150:5-17.
4. Bendotti C, Tortarolo M, Suchak SK, Calvaresi N, Carvelli L, Bastone A, Rizzi M, Rattray M, Mennini T. 2001. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 79:737-746.
5. Bezzi P, Volterra A. 2001. A neuron-glia signalling network in the active brain. Curr Opin Neurobiol 11:387-394.
6. Blanc EM, Keller JN, Fernandez S, Mattson MP. 1998. 4-hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 22:149-160.
7. Boillée S, Vande Velde C, Cleveland DW. 2006. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59.
8. Bondy SC, Lee DK. 1993. Oxidative stress induced by glutamate receptor agonists. Brain Res 610:229-233.
9. Bushong EA, Martone ME, Jones YZ, Ellisman MH. 2002. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 22:183-192.
10. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. 2007. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10:608-614.
11. Duan S, Anderson CM, Stein BA, Swanson RA. 1999. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci 19:10193-10200.
12. Dunlop J, McIlvain HB, She Y, Howland DS. 2003. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. J Neurosci 23:1688-1696.
13. Escartin C, Brouillet E, Gubellini P, Trioulier Y, Jacquard C, Smadja C, Knott GW, Kerkerian-Le Goff L, Deglon N, Hantraye P, Bonvento G. 2006. Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. J Neurosci 26:5978-5989.
14. Fields RD, Stevens-Graham B. 2002. New insights into neuron-glia communication. Science 298:556-562.
15. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD. 2004. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp Neurol 185:232-240.
16. Fournier KM, Gonzalez MI, Robinson MB. 2004. Rapid trafficking of the neuronal glutamate transporter, EAAC1: Evidence for distinct trafficking pathways differentially regulated by protein kinase C, platelet-derived growth factor. J Biol Chem 279:34505-34513.
17. Ganel R, Ho T, Maragakis NJ, Jackson M, Steiner JP, Rothstein JD. 2006. Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol Dis 21:556-567.
18. Gegelashvili G, Civenni G, Racagni G, Danbolt NC, Schousboe I, Schousboe A. 1996. Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes. Neuroreport 8:261-265.
19. 3H]aspartate from cerebral cortical synaptosomes. J Neurochem 62:1757-1763.
20. Ginsberg SD, Martin LJ, Rothstein JD. 1995. Regional deafferentation down-regulates subtypes of glutamate transporter proteins. J Neurochem 65:2800-2803.
21. Greig A, Donevan SD, Mujtaba TJ, Parks TN, Rao MS. 2000. Characterization of the AMPA-activated receptors present on motoneurons. J Neurochem 74:179-191.
22. Gurney ME, Liu R, Althaus JS, Hall ED, Becker DA. 1998. Mutant CuZn superoxide dismutase in motor neuron disease. J Inherit Metab Dis 21:587-597.
23. Heath PR, Shaw PJ. 2002. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 26:438-458.
24. Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD. 2002. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA 99:1604-1609.
25. Hughes EG, Maguire JL, McMinn MT, Scholz RE, Sutherland ML. 2004. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking. Brain Res Mol Brain Res 124:114-123.
26. Keller JN, Mark RJ, Bruce AJ, Blanc E, Rothstein JD, Uchida K, Waeg G, Mattson MP. 1997. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80:685-696.
27. Larm JA, Cheung NS, Beart PM. 1996. (S)-5-fluorowillardiine-mediated neurotoxicity in cultured murine cortical neurones occurs via AMPA and kainate receptors. Eur J Pharmacol 314:249-254.
28. Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC. 1995. Differential expression of two glial glutamate transporters in the rat brain: Quantitative and immunocytochemical observations. J Neurosci 15:1835-1853.
29. Levy LM, Lehre KP, Walaas SI, Storm-Mathisen J, Danbolt NC. 1995. Down-regulation of glial glutamate transporters after glutamatergic denervation in the rat brain. Eur J Neurosci 7:2036-2041.
30. Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Stahlberg A, Aprico K, Larsson K, Yabe T, Moons L, Fotheringham A, Davies I, Carmeliet P, Schwartz JP, Pekna M, Kubista M, Blomstrand F, Maragakis N, Nilsson M, Pekny M. 2007. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 28:468-481.
31. Maragakis NJ, Rothstein JD. 2006. Mechanisms of Disease: Astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2:679-689.
32. Miller RH, Raff MC. 1984. Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct. J Neurosci 4:585-592.
33. Munir M, Correale DM, Robinson MB. 2000. Substrate-induced up-regulation of Na(+)-dependent glutamate transport activity. Neurochem Int 37:147-162.
34. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. 2007. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic tomotor neurons. Nat Neurosci 10:615-622.
35. O'Shea RD, Lau CL, Farso MC, Diwakarla S, Zagami CJ, Svendsen BB, Feeney SJ, Callaway JK, Jones NM, Pow DV, Danbolt NC, Jarrott B, Beart PM. 2006. Effects of lipopolysaccharide on glial phenotype and activity of glutamate transporters: Evidence for delayed upregulation and redistribution of GLT-1. Neurochem Int 48:604-610.
36. Olney JW. 1989. Excitatory amino acids and neuropsychiatric disorders. Biol Psychiatry 26:505-525.
37. Pardo AC, Wong V, Benson LM, Dykes M, Tanaka K, Rothstein JD, Maragakis NJ. 2006. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice. Exp Neurol 201:120-130.
38. Patneau DK, Mayer ML, Jane DE, Watkins JC. 1992. Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine. J Neurosci 12:595-606.
39. Pedersen WA, Cashman NR, Mattson MP. 1999. The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells. Exp Neurol 155:1-10.
40. Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, Mattson MP. 1998. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 44:819-824.
41. Pekny M, Nilsson M. 2005. Astrocyte activation and reactive gliosis. Glia 50:427-434.
42. Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F. 1990. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci 10:1035-1041.
43. Rao SD, Yin HZ, Weiss JH. 2003. Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons. J Neurosci 23:2627-2633.
44. Ridet JL, Malhotra SK, Privat A, Gage FH. 1997. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci 20:570-577.
45. Robberecht W. 2000. Oxidative stress in amyotrophic lateral sclerosis. J Neurol 247:I1-I6.
46. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.
47. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB. 2005. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433:73-77.
48. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. 1995. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73-84.
49. Sathasivam S, Shaw PJ. 2005. Apoptosis in amyotrophic lateral sclerosis - What is the evidence? Lancet Neurol 4:500-509.
50. Schiffer D, Fiano V. 2004. Astrogliosis in ALS: Possible interpretations according to pathogenetic hypotheses. Amyotroph Lateral Scler Other Motor Neuron Disord 5:22-25.
51. Shaw PJ, Eggett CJ. 2000. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol 247:I17-I27.
52. Shobha K, Vijayalakshmi K, Alladi PA, Nalini A, Sathyaprabha TN, Raju TR. 2007. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J Neurol Sci 254:9-16.
53. Sullivan R, Rauen T, Fischer F, Wiessner M, Grewer C, Bicho A, Pow DV. 2004. Cloning, transport properties, and differential localization of two splice variants of GLT-1 in the rat CNS: Implications for CNS glutamate homeostasis. Glia 45:155-169.
54. Trotti D, Danbolt NC, Volterra A. 1998. Glutamate transporters are oxidant- vulnerable: A molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 19:328-334.
55. Trotti D, Rossi D, Gjesdal O, Levy LM, Racagni G, Danbolt NC, Volterra A. 1996. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 271:5976-5979.
56. Valentine J, Doucette PA, Zittin Potter S. 2005. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563-593.
57. Van Damme P, Bogaert E, Dewil M, Hersmus N, Kiraly D, Scheveneels W, Bockx I, Braeken D, Verpoorten N, Verhoeven K, Timmerman V, Herijgers P, Callewaert G, Carmeliet P, Van Den Bosch L, Robberecht W. 2007. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci USA 104: 14825-14830.
58. Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W. 2006. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:1068-1082.
59. 2+-permeable AMPA receptors and selective vulnerability of motor neurons. J Neurol Sci 180:29-34.
60. Volterra A, Trotti D, Tromba C, Floridi S, Racagni G. 1994. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 14:2924-2932.
61. Yamanaka K, Chun SJ, Boillée S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW. 2008. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251-253.
62. Zagami CJ, O'Shea RD, Lau CL, Cheema SS, Beart PM. 2005. Regulation of glutamate transporters in astrocytes: Evidence for a relationship between transporter expression and astrocytic phenotype. Neurotox Res 7:143-149.
63. Zhou J, Sutherland ML. 2004. Glutamate transporter cluster formation in astrocytic processes regulates glutamate uptake activity. J Neurosci 24:6301-6306.